The HypoMon is safe, rigorously tested and easy to use

The HypoMon identifies more sleep-time hypos than any continuous monitoring systems currently available.

The HypoMon identifies sleep-time hypoglycaemia (hypos) in children and young adults aged between 10 and 25 years old, with type 1 diabetes.

Research shows that nearly 55% of severe hypoglycaemia (hypos) in children and adolescents occur at night.

Thanks to HypoMon, correctly identifying sleep-time hypos can be simple and stress free.

The HypoMon correctly identifies 8 out of 10 sleep-time hypos.

Findings from product trials confirm that the HypoMon® alarm system correctly identifies and triggers an alarm for 8 out of 10 night-time hypos.

Clinically proven

The HypoMon has undergone rigorous clinical trials at a leading Australian Children's Hospital. These trials showed that the simple and easy-to-use HypoMon accurately identifies more sleep-time hypoglycaemia than any continuous monitoring systems currently available.

What are the dangers of undetected night-time hypos?

Undetected sleep-time hypoglycaemia, when blood glucose levels drop below 3.8mmol/L (68.4mg/dL) can result in decreased hypoglycaemia awareness for people with type 1 diabetes, and increases the risk of convulsions or coma if untreated.  

Sleep-time hypoglycemia is associated with deterioration in glycemic control in people with type 1 diabetes and is a possible cause of unexplained morning hyperglycemia.

How HypoMon works
1.   The comfortable wrap-around Belt with Sensor and Transmitter collects the user’s physiological changes while they sleep.
2.   Wireless technology transmits the information from the Transmitter to the Monitor that can be placed within a 10-metre radius.
3.   Any changes characteristic of hypoglycaemia trigger alarms at the Transmitter and the Monitor, waking the user and carer.

HypoMon assures a safer, more comfortable night’s sleep for all.

If you would like to know more about the HypoMon, please Contact Us